Filter
61
Featured
9
1
Language
Document type
29
9
7
6
3
3
3
1
Countries / Regions
2
2
2
1
1
1
Authors & Publishers
Publication Years
Category
9
7
1
PATA is an action network of health providers and health facilities in sub-Saharan Africa. Our goal is to effect positive change in paediatric and adolescent HIV policy and service delivery on the frontline.
The PATA network offers a powerful platform for regional collaboration, capacity building
...
The federally approved clinical practice guidelines for HIV/AIDS are developed by panels of experts in HIV care. More information about the panels can be found in each set of guidelines.
The recommendations in these guidelines represent the current, evidence-based consensus of the U.S. Departmen
...
The findings of the report are both urgent and devastating. At the current rate of progress, by 2040 we would still have 1.9 million new HIV infections and 990,000 AIDS-related deaths in children. But if funding for HIV prevention and treatment continues to fall as current trends suggest, the world
...
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
recommended
This document provides an overview of the updated World Health Organization recommendations for HIV clinical management, which focus on optimizing antiretroviral therapy, preventing vertical transmission, and enhancing tuberculosis prevention among individuals with HIV. These updates are intended to
...
In order to ramp up our efforts in the fight against AIDS, there is a need for more concentrated focus on adolescents and young people
About six in ten adolescents 10-19 years of age living with HIV are on antiretroviral medications
Slightly more than half of children under 15 years of age living with HIV are on antiretroviral medications
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations. The guidelines were updated to comply with Executive Orders. You can download the full guidelines, charts and recommendations
AIDS Research and Therapy, vol.22 (2025) article no. 48. A 2025 research article reports on task shifting HIV disclosure support from clinical staff to caregiver peer supporters — indicating a scalable model for community worker involvement in disclosure counseling, which is key for adherence and
...
J Int AIDS Soc. 2025 Jun;28(6):e26526. doi: 10.1002/jia2.26526. PMID: 40515449; PMCID: PMC12166130.
Treatment and care in children and adolescents
recommended
WHO recommends that infants born to mothers living with HIV are tested for HIV by two months of age, during breastfeeding, and when breastfeeding ends given continued risk of transmission during this period. Older children, especially offspring and siblings of persons infected with HIV, should also
...
July 2023 version .The 2023 ART guideline introduces simplified ART provision and harmonised methods of management of children, adolescents and adults, as well as pregnant women living with HIV/AIDS, TB and other common opportunistic infections.
The guidelines also provide guidance on the use of D
...
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi
...
This 5th Edition of the Malawi Guidelines for Clinical Management of HIV in Children and Adults is implemented from January 2022. It replaces all previous editions of the Malawi Antiretroviral therapy (ART) and Prevention of Mother to Child Transmission (PMTCT) guidelines.This document is written fo
...
J Int AIDS Soc. 2022 Nov;25(11):e25970. doi: 10.1002/jia2.25970. PMID: 36377082; PMCID: PMC9663860. These reassuring findings suggest that dolutegravir and raltegravir are effective and safe as preferred regimens in children and adolescents living with HIV. With the rollout of dolutegravir in paedia
...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w
...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w
...
